Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease
<p>Multiple myeloma is a fatal haematological malignancy, in which the majority of patients either present with or develop a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current trea...
Váldodahkki: | |
---|---|
Eará dahkkit: | |
Materiálatiipa: | Oahppočájánas |
Giella: | English |
Almmustuhtton: |
2019
|
Fáttát: |